Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and analyzed a high-risk non–muscle invasive bladder cancer (HR-NMIBC) population using HealthVerity Marketplace. By using linked, privacy-compliant cla...